NUCALA Trademark

Trademark Overview

On Wednesday, May 28, 2014, a trademark application was filed for NUCALA with the United States Patent and Trademark Office. The USPTO has given the NUCALA trademark a serial number of 86293514. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, October 8, 2022. This trademark is owned by Glaxo Group Limited. The NUCALA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders
nucala

General Information

Serial Number86293514
Word MarkNUCALA
Filing DateWednesday, May 28, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, October 8, 2022
Registration Number4900162
Registration DateTuesday, February 16, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of respiratory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 10, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Wednesday, July 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 5, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 5, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 8, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, October 8, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, June 18, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 10, 2022TEAS SECTION 8 & 15 RECEIVED
Tuesday, February 16, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 16, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, December 1, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 27, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 23, 2015SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, March 18, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, March 11, 2015ASSIGNED TO LIE
Tuesday, November 4, 2014ASSIGNED TO EXAMINER
Wednesday, September 10, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 10, 2014LETTER OF SUSPENSION E-MAILED
Wednesday, September 10, 2014SUSPENSION LETTER WRITTEN
Saturday, September 6, 2014ASSIGNED TO EXAMINER
Tuesday, June 10, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 31, 2014NEW APPLICATION ENTERED

Related Keywords

nucala diseases disorders respiratory treatment preparations substances pharmaceutical